Litcius/Paper detail

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

Alain Saraux, Guillermo Carvajal Alegria, Emmanuelle Dernis, Christian Roux, Christophe Richez, Alice Tison, Baptiste Quéré, Sandrine Jousse‐Joulin, Dewi Guellec, Thierry Marhadour, Patrice Kervarrec, Divi Cornec, Catherine Le Hénaff, S. Lesven, Emmanuel Nowak, Aghiles Souki, Valérie Devauchelle‐Pensec

2025The Lancet Rheumatology26 citationsDOI

Topics & Concepts

Polymyalgia rheumaticaDouble blindMedicinePlaceboPlacebo groupPhysical therapyGroup (periodic table)Randomized controlled trialBachelorInternal medicineAlternative medicineGiant cell arteritisPathologyDiseaseOrganic chemistryVasculitisHistoryArchaeologyChemistryVasculitis and related conditionsRheumatoid Arthritis Research and TherapiesOtitis Media and Relapsing Polychondritis
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial | Litcius